Have a personal or library account? Click to login
Evaluation of clinical interventions made by pharmacists in chemotherapy preparation Cover

Evaluation of clinical interventions made by pharmacists in chemotherapy preparation

Open Access
|Sep 2010

References

  1. Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-41.10.1093/ajhp/58.19.183511596700
  2. Ocvirk J, Boc M, Rebersek M, Ros T. Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma. Radiol Oncol 2009; 43: 120-5.10.2478/v10019-009-0005-0
  3. Department of Health. The NHS cancer plan. London: HMSO; 2001.
  4. Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.10.1093/ajhp/57.suppl_4.S411148943
  5. Mort D, Lansdown M, Smith N, Protopapa K, Mason M. For better, for worse? London: National Confidential Enquiry into Patient Outcome and Death; 2008.
  6. North East London Cancer Network NHS. Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London: Department of Health Publications; 2005.
  7. German Society of Oncology Pharmacy. Quality Standard for the Oncology Pharmacy Service with Commentary. 4th Edition. Oldenburg: Onko-press; 2003.
  8. Adams V, Blake D, Corlett S, Godward D, Low J, McMurray A, et al. Competency Framework for Specialist Oncology Pharmacists. BOPA Newsletter, 2004.
  9. Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-8.10.1002/ijc.2399118989899
  10. Jaehde U, Liekwig A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-8.10.1007/s11096-007-9157-4225365217906939
  11. Slama C, Jerome J, Jacquot C, Bonan B. Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-43.10.1007/s11096-005-6034-x16228634
  12. Liekweg A, Westfeld M, Jaehde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 73-9.10.1007/s00520-003-0539-414530957
  13. Debevec L, Jerič T, Kovač V, Bitenc M, Sok M: Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.10.2478/v10019-009-0008-x
  14. Knez L, Laaksonen R, Duggan C, Nijjar R. Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-80.
  15. Burtonwood AM, Hinchliffe AL, Tinkler GG. A prescription for quality: a role for the clinical pharmacist in general practice. Pharm J 1998; 261: 678-80.
  16. Eadon H. Assessing the quality of ward pharmacists' interventions. Int J Pharm Practice 1992; 1: 145-7.10.1111/j.2042-7174.1992.tb00556.x
  17. Price RN, Rogers A. Intervention monitoring on admissions wards. Hosp Pharmacists 2000; 7: 81-4.
  18. Barber N, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 1997; 54: 397-405.10.1093/ajhp/54.4.3979043562
  19. Hawkey CJ, Hodgon S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. Br Med J 1990; 300: 986-990.10.1136/bmj.300.6730.98616627012344509
  20. Allan EL, Barker KN. Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-71.
  21. Bowling A. Research methods in health. Philadelphia: Open University Press; 2002.
  22. Macintyre J, Dalrymple H, MacLean F, Lannigan N, Hudson S. Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-7.
  23. Limat S, Drouhin JP, Demesmay K, Tissot E, Jacquet M, Woronoff-Lemsi MC. Incidence and risk factors of preparation errors in centralized cytotoxic preparation unit. Pharm World Sci 2001; 23: 102-6.10.1023/A:1011252132478
  24. Bourret JA, Demeres RF, Wordell D, Irani M, Baker J, Evangelista C. Medication use review process and information systems utilized for oncology chemotherapy quality improvement. Pharm Pract Manag Q 1996; 16: 1-17.
  25. Barber N, Cornford T, Klecun E. Qualitative evaluation of an electronic prescribing and administration system. Qual Saf Health Care 2007; 16: 271-8.10.1136/qshc.2006.019505246493717693675
  26. Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005; 165: 1111-6.10.1001/archinte.165.10.111115911723
DOI: https://doi.org/10.2478/v10019-010-0040-x | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 249 - 256
Published on: Sep 22, 2010
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Lea Knez, Raisa Laaksonen, Catherine Duggan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 4 (December 2010)